For research use only. Not for therapeutic Use.
Moxisylyte Hydrochloride(CAT: I005701) is an adrenergic antagonist specifically targeting alpha-1 adrenergic receptors, widely used in vascular and urological research. Known for its vasodilatory properties, it is particularly valuable for studying conditions involving impaired blood flow, such as peripheral vascular disease and erectile dysfunction. Moxisylyte Hydrochloride facilitates investigations into adrenergic signaling pathways, smooth muscle relaxation, and vascular function. With high purity and consistent activity, it is suitable for in vitro and in vivo studies, providing researchers with a reliable tool for exploring therapeutic approaches to vascular and circulatory disorders.
Catalog Number | I005701 |
CAS Number | 964-52-3 |
Molecular Formula | C16H26ClNO3 |
Purity | ≥95% |
Target | Neuronal Signaling |
Solubility | Soluble in ethanol (50 mg/ml). |
Storage | 3 years -20C powder |
IUPAC Name | [4-[2-(dimethylamino)ethoxy]-2-methyl-5-propan-2-ylphenyl] acetate;hydrochloride |
InChI | InChI=1S/C16H25NO3.ClH/c1-11(2)14-10-15(20-13(4)18)12(3)9-16(14)19-8-7-17(5)6;/h9-11H,7-8H2,1-6H3;1H |
InChIKey | IPWGSXZCDPTDEH-UHFFFAOYSA-N |
SMILES | CC1=CC(=C(C=C1OC(=O)C)C(C)C)OCCN(C)C.Cl |